Clinical trial
Safety, Tolerability and Pharmacokinetic Study of Single and Multiple…
NCT00416442 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00416442 |
|---|---|
| Title | Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects. |
| Official title | A Randomized, Double-blind Placebo-controlled Single- to Multiple-dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of RSV604 Intravenous Formulation in Healthy Subjects |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | RSV604 |
| Enrollment | 48 |
| Start date | Oct 1, 2006 |
| Primary completion | Nov 1, 2006 |
| First posted | Dec 28, 2006 |
| Last update posted | Nov 2, 2011 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: